Institut Català de la Salut
[Pozo-Rosich P, Caronna E, Torres-Ferrus M] Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Veelen N, van der Arend BWH] Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. [Vaghi G] Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. Headache Science and Neurorehabilitation Center, IRCCS Mondino Foundation, Pavia, Italy
Vall d'Hebron Barcelona Hospital Campus
2025-04-29T10:56:23Z
2025-04-29T10:56:23Z
2025
Adverse event; Patient reported outcome measures; Real world evidence
Evento adverso; Medidas de resultados informadas por el paciente; Evidencia del mundo real
Esdeveniment advers; Mesures de resultat informades pel pacient; Evidència del món real
Real-world evidence studies are an important tool for investigating the effectiveness, safety and tolerability of treatments for headache disorders in clinical practice. These studies use data generated from routine clinical practice from a variety of sources and can help to identify unmet needs in headache care and guide new therapies, including populations not always included in randomized clinical trials of different ages, comorbidities, and concomitant stable treatments. Real-world evidence pertains to the clinical evidence surrounding the utilization, as well as the potential advantages or drawbacks of treatment, which is extracted through an analysis of real-world data. Real-world evidence studies can present unique challenges, including timing of data collection (prospective vs retrospective), data selection, data quality issues and potential biases (selection, confounding factors, etc.). The International Headache Society has developed these guidelines for optimizing the design and conduct of real-world evidence studies, and therefore the strength and reliability of their output.
Article
Versió publicada
Anglès
Migranya - Tractament; Cefalàlgia - Tractament; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Headache Disorders::Headache Disorders, Primary::Trigeminal Autonomic Cephalalgias::Cluster Headache; Other subheadings::Other subheadings::Other subheadings::/drug therapy; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Headache Disorders::Headache Disorders, Primary::Migraine Disorders; Other subheadings::Other subheadings::Other subheadings::/drug therapy; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos con cefaleas::cefaleas primarias::cefalalgia autónoma del trigémino::cefalea histamínica; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos con cefaleas::cefaleas primarias::trastornos migrañosos; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
SAGE Publications
Cephalalgia;45(3)
https://doi.org/10.1177/03331024251318016
info:eu-repo/grantAgreement/ES/PE2017-2020/CM20%2F00217
Attribution-NonCommercial 4.0 International
http://creativecommons.org/licenses/by-nc/4.0/
Articles científics - VHIR [1655]